Stay updated on Pembrolizumab & Enobosarm in AR+ Metastatic TNBC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab & Enobosarm in AR+ Metastatic TNBC Clinical Trial page.

Latest updates to the Pembrolizumab & Enobosarm in AR+ Metastatic TNBC Clinical Trial page
- ChecktodayNo Change Detected
- Check8 days agoChange DetectedThe page revision tag updated to v3.5.3 from v3.5.2. This reflects a minor update to the record and does not affect the study data.SummaryDifference0.1%

- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedRevision: v3.5.2 added and v3.5.0 removed. No substantive study content appears to be affected.SummaryDifference0.1%

- Check50 days agoChange DetectedAdded Revision: v3.5.0 and removed Revision: v3.4.3. This appears to be an internal documentation/version update and does not alter the study details or results.SummaryDifference0.1%

- Check58 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3. The change reflects a version label update with no alterations to page content or functionality.SummaryDifference0.1%

- Check86 days agoChange DetectedAddition: Revision: v3.4.2 is now active; the previous government funding lapse notice (v3.4.1) has been removed, reflecting administrative site-wide updates rather than study data changes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check93 days agoChange DetectedAdded a government funding notice stating information may not be up to date and directing users to status updates. Updated the site revision from v3.4.0 to v3.4.1.SummaryDifference0.4%

Stay in the know with updates to Pembrolizumab & Enobosarm in AR+ Metastatic TNBC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab & Enobosarm in AR+ Metastatic TNBC Clinical Trial page.